PM360

NOVEMBER 14, 2023

However, in August news outlets reported that even with industry and government initiatives to lower the cost of insulin, the implementation had been slow due to healthcare system “mechanics,” and a significant number of consumers had not yet benefited from the $35 insulin options. for only $35. Currently, an estimated 37.3 of the U.S.

Retail 52

Retail Pharmaceutical manufacturing Sales Insurance 52

pharmaphorum

JANUARY 24, 2023

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.

Medicine 95

Medicine Healthcare Healthcare Pharma 95

pharmaphorum

OCTOBER 3, 2022

The third ALS treatment to be given FDA approval, following Mitsubishi Tanabe’s Radicava ($170,000 per year) and generic drug riluzole – Relyvrio is priced at around $12,500 per 28-day prescription. Clearer’ data isn’t expected until 2024, with results from a late-stage phase 3 PHOENIX trial of around 600 patients due at that time.

Insurance 52

Insurance Prescription FDA Patients 52

Nixon Gwilt Law

JANUARY 16, 2024

What can digital health innovators and investors anticipate for the industry in 2024? What can digital health innovators and investors anticipate for the industry in 2024? We asked our team to share their insights on healthcare innovation, new regulations, and trends we expect to impact your business this year. We know a few!

Healthcare 52

Healthcare Healthcare Management Insurance 52

Clarivate

OCTOBER 30, 2022

Of surveyed MCOs that cover or plan to cover DTx apps for the three conditions, more than 80% of respondents reported reimbursing DTx for at least one of the conditions in their fully insured commercial plans as of March 2022, with the remainder expecting to do so by 2024. Payers also noted some coverage in their Medicare and Medicaid plans.

Insurance 52

Insurance FDA Prescription Marketing 52

PM360

NOVEMBER 13, 2023

Improving healthcare and patient outcomes requires that stakeholders communicate and collaborate, and GoodRx is one of the few places where providers, patients, and pharma can connect every single day. That’s rare in healthcare, and we believe it likely improves communication and joint decision making along their health journey together.

Media 52

Media Prescription Healthcare Provider Patients 52

Clarivate

DECEMBER 19, 2022

Insurers that incentivize using Walmart facilities in Medicare Advantage and prescription drug plans (PDPs) have seen success; Humana has a long-running standalone Part D plan with Walmart pharmacies as preferred network locations. To learn more about how Clarivate helps life science companies navigate the fast-changing U.S.

Competition 52

Competition Retail Insurance Marketing 52

Clarivate

MAY 13, 2024

According to Clarivate’s latest enrollment data, as of January 2024, Medicaid enrollment had plummeted by nearly 9 million compared to six months prior. For 2024, 18% of enrollees were new to exchange coverage, according to the Centers for Medicare and Medicaid Services. million between January 2023 and January 2024. to about 2.5

Insurance 52

Insurance Marketing Healthcare Healthcare 52

PM360

SEPTEMBER 21, 2023

This product would be a more potent prescription version than the OTCs, Casberg notes. In 2024, ARPA removes the 100% AMP cap. The company says it will produce two million doses a year and give away half of them for free, while the rest will be sold at roughly $18 per dose.

Management 105

Management Manufacturing Sales Competition 105

PM360

MARCH 22, 2024

CMI Media Group has a strong and lasting heritage in the United States, known for highly effective healthcare audience reach. For nearly 35 years, CMI has been the leader in the American healthcare media landscape, fully focused on delivering successful media strategies to U.S.-based prescribers. The need for a media consolidation.

Media 59

Media Healthcare Healthcare Marketing 59

PM360

SEPTEMBER 28, 2022

In April 2022, we released an article describing proposed policies from the federal government that could impact prescription drug pricing. healthcare system with major implications for the Medicare Advantage and Medicare Part D programs. On August 16, 2022, President Biden signed the Inflation Reduction Act (IRA) into law.

Government 97

Government Manufacturing Prescription Competition 97

European Pharmaceutical Review

JANUARY 5, 2023

Triomphe added: “… it is our intention to make nirsevimab available, if approved in time, for the 2023/2024 season to help alleviate the burden of RSV on families and the healthcare system.”. The Prescription Drug User Fee Act date, the FDA target action date for their decision, is in the third quarter of 2023.

Food and Drug Administration 59

Food and Drug Administration FDA Safety Prescription 59

PM360

NOVEMBER 12, 2023

We can expect individual states to continue advancing their own privacy legislation, and cookies are officially disappearing after June 30, 2024, to boot. And what are the best tools and techniques to optically target patients and healthcare providers without running afoul of new regulations?

Patients 52

Patients Marketing Medical Pharmaceutical 52

PM360

DECEMBER 20, 2023

A significant battle for the hearts and minds of healthcare professionals (HCPs) will play out in social media during 2024. Fifty percent of responders said they changed prescriptions because of social media information.

Media 122

Media Physicians Pharma reps Pharma Rep 122

Pharmaceutical Technology

JANUARY 16, 2023

The legislation contains several provisions to lower prescription drug costs, including allowing Medicare to negotiate the cost of selected medicines. Negotiations over these products are expected from October 2023 and run until August 2024. What is the Global Healthcare and Pharma Market Q2 Outlook? Free Report.

Pharma 64

Pharma Manufacturing Pharmaceutical Marketing 64

Pharmaceutical Technology

JANUARY 6, 2023

Ex-Novartis sales representative Steven Camburn filed a whistleblower case that claimed Novartis had paid doctors up to $3,500 to participate in educational speaker programs to increase the promotion and prescription of Gilenya. However, Novartis did not get the same reception while facing similar allegations in Greece.

Pharmaceutical 97

Pharmaceutical Doctors Healthcare Provider Prescription 97

Pharmaceutical Technology

JANUARY 16, 2023

The legislation contains several provisions to lower prescription drug costs, including allowing Medicare to negotiate the cost of selected medicines. Negotiations over these products are expected from October 2023 and run until August 2024. What is the Global Healthcare and Pharma Market Q2 Outlook? Free Report.

Pharma 52

Pharma Manufacturing Pharmaceutical Marketing 52

Pharmaceutical Technology

DECEMBER 4, 2022

Broadly speaking, price is the determining factor on the US healthcare market, says Jakub Hlávka, PhD, research assistant professor of health policy and management at the University of South California, Los Angeles. Samsung Bioepis and Organon previously stated that Hadlima's interchangeability data should be ready in 2024.

Marketing 104

Marketing Physicians Competition Patients 104

World of DTC Marketing

MARCH 30, 2022

Roughly 1 in 4 adults report difficulty affording their prescription drugs, according to KFF polling. Healthcare spending is supposed to climb during the next decade, and it’s profitable for the players. According to KHN.org, Congress is under intense pressure to rein in the high prices of medicines in the U.S., Ron Wyden (D-Ore.),

Pharma 189

Pharma Prescription Insurance Doctors 189

Pharmaceutical Technology

DECEMBER 2, 2022

These results have important implications for the pharmaceutical industry and US healthcare sector over the next two years. After the mid-term election results, former President Donald Trump also announced his intention to run for re-election in the 2024 presidential election.

Pharma 59

Pharma Government Healthcare Healthcare 59